COVID-19 Information and Resources
The health and safety of patients,
healthcare professionals and our employees is our highest priority. GBT
supports and is aligned with public health strategies designed to stem the
spread of COVID-19. We are committed to doing our part to reduce the risk of
spreading the virus, while we remain focused on meeting the needs of our
We are closely monitoring the evolving COVID-19 pandemic, and we will continue to update this page with additional information and resources as they become available.
GBT has contributed more than $350,000 to support the sickle cell disease (SCD) community during the COVID-19 pandemic through grants from the newly created GBT Community Fund to U.S. nonprofit organizations, a donation to the Sickle Cell Disease Association of America and personal contributions from GBT’s board of directors and employees.